As of 2025-10-29, the Relative Valuation of Medexus Pharmaceuticals Inc (MDP.TO) is 1.72 CAD. This relative valuation is based on P/E multiples. With the latest stock price at 2.87 CAD, the upside of Medexus Pharmaceuticals Inc based on Relative Valuation is -39.9%.
The range of the Relative Valuation is 1.12 - 2.63 CAD.
| Range | Selected | |
| Trailing P/E multiples | 44.6x - 50.5x | 47.6x |
| Forward P/E multiples | 22.9x - 31.7x | 27.3x |
| Fair Price | 1.12 - 2.63 | 1.72 |
| Upside | -61.1% - -8.4% | -39.9% |
| Date | P/E |
| 2025-10-27 | 115.67 |
| 2025-10-24 | 114.87 |
| 2025-10-23 | 114.07 |
| 2025-10-22 | 109.27 |
| 2025-10-21 | 110.07 |
| 2025-10-20 | 115.27 |
| 2025-10-17 | 108.07 |
| 2025-10-16 | 110.87 |
| 2025-10-15 | 111.67 |
| 2025-10-14 | 111.67 |
| 2025-10-10 | 108.47 |
| 2025-10-09 | 114.07 |
| 2025-10-08 | 116.87 |
| 2025-10-07 | 113.67 |
| 2025-10-06 | 112.07 |
| 2025-10-03 | 114.47 |
| 2025-10-02 | 116.07 |
| 2025-10-01 | 102.46 |
| 2025-09-30 | 104.06 |
| 2025-09-29 | 107.67 |
| 2025-09-26 | 110.87 |
| 2025-09-25 | 118.87 |
| 2025-09-24 | 119.67 |
| 2025-09-23 | 117.67 |
| 2025-09-22 | 119.67 |
| 2025-09-19 | 121.28 |
| 2025-09-18 | 117.27 |
| 2025-09-17 | 118.47 |
| 2025-09-16 | 118.87 |
| 2025-09-15 | 120.87 |
| 2025-09-12 | 121.28 |
| 2025-09-11 | 124.08 |
| 2025-09-10 | 124.48 |
| 2025-09-09 | 122.88 |
| 2025-09-08 | 124.88 |
| 2025-09-05 | 123.28 |
| 2025-09-04 | 122.08 |
| 2025-09-03 | 122.88 |
| 2025-09-02 | 122.08 |
| 2025-08-29 | 122.08 |
| 2025-08-28 | 124.48 |
| 2025-08-27 | 124.48 |
| 2025-08-26 | 114.07 |
| 2025-08-25 | 114.07 |
| 2025-08-22 | 114.87 |
| 2025-08-21 | 114.07 |
| 2025-08-20 | 118.47 |
| 2025-08-19 | 112.47 |
| 2025-08-18 | 114.07 |
| 2025-08-15 | 118.07 |